Articles tagged with: ENZN
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) has announced that they have set Wednesday, January 27, 2010 as the date of the special meeting of stockholders to vote on the proposed sale of its specialty pharmaceutical business to …
Enzon Pharmaceuticals, Inc (NASDAQ:ENZN) has announced that they have entered into a definitive agreement to sell their specialty pharmaceutical business to Sigma-Tau Group for US$300 million along with milestone payments of US$27 million.
On a Monday afternoon, Enzon Pharmaceuticals made an announcement that FDA Oncologic Drug Advisory Committee has voted in the favor of and has approved the use of Pegintron as a treatment in addition to surgery …




